International Myotonic Dystrophy Organization
 
Untitled Document
Sections
Untitled Document

 
NIH Workshop 2005
Workshop on the Burden of Muscle Diseases at the National Institute of Health Bethesda, MD January 26-27th 2005

The National Institute of Health in the United States of America held a workshop on the Burden of Muscle Diseases on the above dates. The US congress mandated by law that an estimate of the social and economic impact of these neuromuscular diseases be measured. The following are my notes and information about this meeting. (Richard Weston January 26th 2005) Please note that speakers sometimes talked fast and I could not make notes but we will add the link to the official site when that is one. It is very evident that because of motivation/Apathy Issues in that people with DM are being underreported in the area.

Richard's Summary: It is important to measure the burden of muscle diseases so that it will be more evident of the impacts and greater resources can be devoted to management and treatment. The social burden is the difference between a person's expectations and reality. The economic burden will be studied tomorrow. For caregiving the major factors that affect parents is the Child's behavior and also ambulation (or needed cane or wheelchair). There is a major study ongoing regarding support and DM1 in Canada. This will have interesting and long-lasting results.

Introduction

Moderators
    Richard Lymn, PhD/Niams/NIH
    Richard Moxley III MD University of Rochester

Untitled Document
Fact Sheets
WorkShop Goals - Richard Lymn
Defining Chronic Muscle Disease - Craig McDonald, UC Davis
Myotonic Dystrophy DM1
Congenital Form DM1
FacioScapuloHumerial Dystrophy FSHD
Muscular Dystrophies - Richard Moxley III
Assessing the Burden of an Illness James Schuttinga, Phd NIH
Approaches to Burden of Illness in Canada Micheal Wolfson Phd Statistics Canada
Discussions:
Personal and Family Factors
Parental Perspectives Pat Furlong Parent Project Muscular Dystrophy
Multi-Generational Aspects - William G. Micheal, CPA FSH Muscular Dystrophy Society
Views on Disease Management of Muscular Dystrophy - Margaret Bowler, Myotonic Dystrophy Support Group UK
Myotonic Dystrophy Support Groups in USA - Shannon Lord, Atlanta GA
Discussions
Health and Pyschosocial Burdens
Quality of Life and Social Issues in Myotonic Dystrophy Cynthia Gagon, MSc. Carrefour de sante de Jonquiere
Measuring Quality of Life (QoL) in Adolescents with Disabilites and Chronic Conditions - Tari Topolski PhD University of Washington
Burden of Adult Muscle Diseases Micheal Rose MD Kings College London
Advances in Healthcare Outcomes Measurement Bryce Reeve, PhD National Cancer Institute/NIH
Patient Reported Outcomes Measure Deborah Alder, PhD NIAMS/NIH
Sources of Epidemiological Data Aileen Kenneson, Phd
Duchenne Muscular Dystrophy Survey Eric Henricson MPH Childrens National Medical Center Washington DC
National Registry for Myotonic Dystrophy and FSH Dystrophy Patients and Families - Richard Moxley III
Disease Specific QoL Instruments - Arthritis Deborah Lubeck PhD Amgen Dimensions of Quality of Life
Qol: Issues for Persons with Neuromuscular Diseases Ted Abresch MS UC Davis
 
Copyright 2007- All Rights Reserved.